Danaher Schedules First Quarter 2021 Earnings Conference Call

WASHINGTON, March 25, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2021 on Thursday, April 22, 2021 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the “Investors” section of Danaher’s... Read more

Thermo Fisher Scientific Completes FDA Listing and Launches the Applied Biosystems QuantStudio 5 Dx Real-Time PCR System for In Vitro Diagnostic Use

Thermo Fisher Scientific Completes FDA Listing and Launches the Applied Biosystems QuantStudio 5 Dx Real-Time PCR System for In Vitro Diagnostic Use Innovative qPCR platform simplifies molecular diagnostic workflows for infectious disease, oncology and COVID-19 testing CARLSBAD, Calif., March 25, 2021 /PRNewswire/ — Thermo Fisher Scientific today announced the completion of the U.S. Food and Drug... Read more

Illumina Announces Board Changes

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) (the “Company”) today announced that Jay Flatley has decided to step down from the Board of Directors and John W. Thompson will be appointed as the Company’s new Chair of the Board. These changes will be effective as of the Company’s Annual Shareholder Meeting on May 26, 2021. This... Read more

Bio-Techne Announces ISO 9001:2015 Certification for Its Bristol Manufacturing Facility.

MARCH 15, 2021 MINNEAPOLIS, March 15, 2021 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today announced that its Bristol site in the United Kingdom received ISO 9001:2015 Quality Management Systems certification. Bio-Techne’s Bristol facility produces life science reagents for... Read more

PCR Biosystems launches advanced Bst Polymerase reagents for accelerated DNA and RNA amplification

Mar 10, 2021 PCR Biosystems, the UK-based specialists in DNA and RNA analysis, have launched a range of IsoFast™ Bst Polymerase reagents for rapid, robust and sensitive DNA and RNA amplification. Through its nucleic acid strand displacement capabilities, Bst polymerase eliminates the need for the high temperature denaturation step associated with traditional Taq enzymes. This enables faster... Read more

Dr. Katharine Knobil Named Agilent’s First Chief Medical Officer

SANTA CLARA, Calif., March 09, 2021  Agilent Technologies Inc. (NYSE: A), today announced that Dr. Katharine (Kate) Knobil is joining Agilent as the company’s chief medical officer (CMO). The chief medical officer at Agilent is a newly created position designed to advise, lead, and elevate the company’s presence in the health-care industry. As Agilent’s first... Read more

10x Genomics Expands Pleasanton Headquarters with New Facilities at Two Locations

City to Change Street Name to ‘Genomics Place’ PLEASANTON, Calif., March 09, 2021 (GLOBE NEWSWIRE) — 10x Genomics, Inc. (Nasdaq: TXG) today announced expansion plans to support the company’s continued growth in Pleasanton across two properties. Along with the leasing of a second building in the same complex as its current headquarters, 10x has acquired the... Read more

Illumina and R-Pharm Secure Registration for Two Complete IVD Sequencing Platforms in Russia

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc.’s (NASDAQ: ILMN) NextSeq™ 550Dx platform and associated reagent kits received medical device registration in Russia, as have reagents for the MiSeq™Dx which was approved previously as a medical device. Both of these in vitro diagnostic (IVD)-ready solutions are available to customers and third-party developers to create diagnostic solutions using the technology.... Read more

10x Genomics Showcases Next Wave of Innovations at First Ever Xperience Event

Acquires Tetramer Shop; Reveals Details on Upcoming Products PLEASANTON, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) — 10x Genomics, Inc. (Nasdaq: TXG) today detailed a slew of new products and announced the acquisition of Copenhagen-based Tetramer Shop at its inaugural Xperience 2021 event, a showcase with three breakout sessions corresponding to 10x’s three product platforms:  Chromium Single... Read more

QIAGEN and INOVIO expand collaboration to develop next generation sequencing (NGS) companion diagnostic for INOVIO’s VGX-3100 for advanced cervical dysplasia

PLYMOUTH MEETING, PA., USA, and GERMANTOWN, MD., USA, and HILDEN, Germany, February 24, 2021 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and INOVIO Pharmaceuticals (NASDAQ: INO) today announced an extension of their partnership with a new master collaboration agreement to develop liquid biopsy-based companion* diagnostic products based on next-generation sequencing (NGS) technology to complement... Read more